HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\)
Clinical trials for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\) explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\) trials appear
Sign up with your email to follow new studies for HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart study seeks link between blood flow and walking ability
Knowledge-focused Recruiting nowThis study involves 20 adults with hypertrophic obstructive cardiomyopathy (HOCM) who are already on standard medications. Researchers want to see if changes in heart blood flow over one year are linked to how far patients can walk in six minutes. Participants will have two heart…
Matched conditions: HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\)
Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated May 26, 2026 07:26 UTC
-
Heart drug camzyos may do more than relieve blockage – new study investigates
Knowledge-focused Recruiting nowThis study looks at whether the medication Camzyos (mavacamten) improves blood supply to the heart muscle in people with hypertrophic obstructive cardiomyopathy (HOCM). About 75 adults already prescribed Camzyos will get a special PET scan before starting the drug and again after…
Matched conditions: HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY \(HOCM\)
Phase: NA • Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC